# Trigger Point Injection for Myofascial Pain Syndrome in the Low Back: A Randomized Controlled Trial

> **NCT04704297** · PHASE4 · RECRUITING · sponsor: **Madigan Army Medical Center** · enrollment: 180 (estimated)

## Conditions studied

- Low Back Pain
- Myofascial Pain Syndrome Lower Back

## Interventions

- **DRUG:** Treatment of Myofascial Pain Syndrome in the low back. This intervention will be based on outcomes of the medications listed below.
- **DRUG:** Evaluation of functional ability using a patient centered functional score known as the Modified Oswestry Disability Index (MODI). The intervention will be based on outcomes of medications below.
- **DRUG:** Following up with participants 60-72 hours after treatment in the Emergency Department. This intervention will be based on outcomes of the medications listed below.

## Key facts

- **NCT ID:** NCT04704297
- **Lead sponsor:** Madigan Army Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-12-28
- **Primary completion:** 2022-07-01
- **Final completion:** 2022-07-01
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2021-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04704297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04704297, "Trigger Point Injection for Myofascial Pain Syndrome in the Low Back: A Randomized Controlled Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04704297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*